We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,655 results
  1. Immediate hypersensitivity reaction to levetiracetam: a case report study

    Background

    Anticonvulsant drugs are one of the most common causes of delayed hypersensitivity reactions, such as drug reaction with eosinophilia and...

    Mahnaz Sadat Hosseini, Soha Namazi in DARU Journal of Pharmaceutical Sciences
    Article 02 November 2023
  2. Therapeutic Effect of Levetiracetam Against Thioacetamide-Induced Hepatic Encephalopathy Through Inhibition of Oxidative Stress and Downregulation of NF-κB, NLRP3, iNOS/NO, Pro-Inflammatory Cytokines and Apoptosis

    Hepatic encephalopathy (HE) is a serious brain disorder which associated with neurological and psychiatric manifestations. Oxidative stress and...

    Keyvan Amirshahrokhi, Mahsa Imani in Inflammation
    Article 26 March 2024
  3. Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil

    Epilepsy is a common neurological disorder that is primarily treated with antiseizure medications (ASMs). Although dozens of ASMs are available in...

    Peng-Peng Wu, Bi-Rong Cao, ... Zhao-Bing Gao in Neuroscience Bulletin
    Article 28 October 2023
  4. Safety and efficacy of levetiracetam and carbamazepine monotherapy in the management of pediatric focal epilepsy: a randomized clinical trial

    Due to the limited number of studies in children with focal epilepsy and the importance of choosing the most suitable drug to control seizures in...

    Hadi Montazerlotfelahi, Arsh Haj Mohamad Ebrahim Ketabforoush, ... Sanaz Tajfirooz in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 24 January 2024
  5. Levetiracetam Modulates EEG Microstates in Temporal Lobe Epilepsy

    To determine the effects of Levetiracetam (LEV) therapy using EEG microstates analysis in a population of newly diagnosed Temporal Lobe Epilepsy...

    Lorenzo Ricci, Pierpaolo Croce, ... Giovanni Assenza in Brain Topography
    Article Open access 13 September 2022
  6. Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy

    Background

    Epilepsy is a major symptom in patients with glioma. Levetiracetam (LEV) is recognized as a first-line treatment for glioma-related...

    Etsuko Yamamoto Hattori, Yoshiki Arakawa, ... Susumu Miyamoto in BMC Cancer
    Article Open access 11 September 2023
  7. Levetiracetam-associated pancytopenia

    Rumeysa Unkun, Esra Kochan Kizilkilic, ... Cigdem Ozkara in Acta Neurologica Belgica
    Article 07 November 2022
  8. Effect of Nonadherence on Levetiracetam Pharmacokinetics and Remedial Dose Recommendations Using Monte Carlo Simulations

    Background and Objective

    Nonadherence to levetiracetam (LEV) use can result in subtherapeutic concentrations and increase the risk of the occurrence...

    Article 27 June 2022
  9. Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model

    Expression of inhibitory designer receptors exclusively activated by designer drugs (DREADDs) on excitatory hippocampal neurons in the hippocampus...

    Jana Desloovere, Paul Boon, ... Robrecht Raedt in Neurotherapeutics
    Article 03 December 2021
  10. Objective and Subjective Assessment of the Effect of Levetiracetam on Daytime Sleepiness in Patients with Epilepsy

    Background

    Levetiracetam (LEV) is a newer generation antiepileptic drug with unique anticonvulsive mechanism of action. It has been reported to cause...

    O. Chaneva, Ekaterina Viteva, A. Yaneva in Sleep and Vigilance
    Article 14 June 2023
  11. Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer’s disease

    Alzheimer’s disease (AD) is the most common neurodegenerative disorder among the elderly. In the light of increasing AD prevalence and lack of...

    Mohaddeseh Sadat Alavi, Sahar Fanoudi, ... Hamid R. Sadeghnia in Metabolic Brain Disease
    Article 31 January 2022
  12. Correction to: The Antiepileptic Drug Levetiracetam Protects Against Quinolinic Acid-Induced Toxicity in the Rat Striatum

    Maricela Dircio-Bautista, Ana Laura Colín-González, ... Abel Santamaría in Neurotoxicity Research
    Article 08 July 2023
  13. Taste Masking Study Based on an Electronic Tongue: the Formulation Design of 3D Printed Levetiracetam Instant-Dissolving Tablets

    Purpose

    Proper taste-masking formulation design is a critical issue for instant-dissolving tablets (IDTs). The purpose of this study is to use the...

    Zengming Wang, **gru Li, ... Ai** Zheng in Pharmaceutical Research
    Article Open access 11 May 2021
  14. Levetiracetam treatment leads to functional recovery after thoracic or cervical injuries of the spinal cord

    Spinal cord injury (SCI) leads to dramatic impairments of motor, sensory, and autonomic functions of affected individuals. Following the primary...

    Rui Lima, Eduardo D. Gomes, ... Nuno A. Silva in npj Regenerative Medicine
    Article Open access 02 March 2021
  15. Albumin nanoparticles coated with polysorbate 80 for the targeted delivery of antiepileptic drug levetiracetam into the brain

    The aim of the study was to target levetiracetam (LEV) into the brain by albumin nanoparticles. The levetiracetam-loaded albumin nanoparticles...

    Barnabas Wilson, Janani Selvam, ... Josephine L. Jenita in Drug Delivery and Translational Research
    Article 11 August 2020
  16. Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes

    Levetiracetam (LEV) and oxcarbazepine (OXC) are commonly used in the treatment of epilepsy, but their efficacy and safety have seldom been compared...

    Gui-hai Suo, Yu-qin Zheng, ... Ji-hong Tang in Acta Neurologica Belgica
    Article Open access 15 February 2021
  17. Percutaneous delivery of levetiracetam as an alternative to topical nonsteroidal anti-inflammatory drugs: formulation development, in vitro and in vivo characterization

    The study focused on formulation of carmellose sodium hydrogels and nonionic microemulsions with 5% and 10% of levetiracetam and investigation of...

    Ljiljana Djekic, Bojan Marković, ... Radica Stepanović-Petrović in Drug Delivery and Translational Research
    Article 25 May 2020
  18. Epilepsy in Angelman’s Syndrome

    Objectives . To study the neurological status, clinical/EEG patterns, neuroimaging, and the course of epilepsy in children with genetically confirmed...

    M. Yu. Bobylova, K. Yu. Mukhin, ... O. A. Pylayeva in Neuroscience and Behavioral Physiology
    Article 01 March 2023
  19. Effects of New-Generation Antiepileptic Drug Prophylaxis on Delayed Neurovascular Events After Aneurysmal Subarachnoid Hemorrhage

    Neuroelectric disruptions such as seizures and cortical spreading depolarization may contribute to the development of delayed cerebral ischemia (DCI)...

    Hidenori Suzuki, Yoichi Miura, ... Naoki Toma in Translational Stroke Research
    Article 05 November 2022
  20. Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines

    Glioblastoma multiforme is the most common malignant primary brain tumor in adults. Despite new treatments developed including immunomodulation using...

    Kevin Doello, Cristina Mesas, ... Raúl Ortiz in Neurotoxicity Research
    Article Open access 30 November 2022
Did you find what you were looking for? Share feedback.